Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30

$0.37+0.01 (+2.77%)

Close on Nov 13, 2026Market cap $3.23MP/E 0.3Yield –

Evogene price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Evogene's price to sales ratio was 1.4× on Nov 11, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 1.0× to 64.1×, with a median of 11.9×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	1.4×	−0.3
2025	Dec 31, 2025	1.7×	−1.5
2024	Dec 31, 2024	3.2×	−17.7
2023	Dec 29, 2023	20.9×	−10.1
2022	Dec 30, 2022	31.0×	−33.0
2021	Dec 31, 2021	64.1×	−96.7
2020	Dec 31, 2020	160.8×	+138.3
2019	Dec 31, 2019	22.4×	+7.3
2018	Dec 31, 2018	15.1×	+3.1
2017	Dec 29, 2017	12.0×	+0.3
2016	Dec 30, 2016	11.6×	–